None
Quote | Selecta Biosciences Inc. (NASDAQ:SELB)
Last: | $0.8812 |
---|---|
Change Percent: | 7.42% |
Open: | $0.8867 |
Close: | $0.8812 |
High: | $0.9399 |
Low: | $0.81 |
Volume: | 2,770,271 |
Last Trade Date Time: | 11/13/2023 03:00:00 am |
News | Selecta Biosciences Inc. (NASDAQ:SELB)
2023-11-13 08:41:26 ET More on Selecta Biosciences Selecta Biosciences GAAP EPS of -$0.07 beats by $0.01, revenue of $5.2M misses by $5.89M Seeking Alpha’s Quant Rating on Selecta Biosciences Historical earnings data for Selecta Biosciences Financial i...
– Merger creates a fully integrated, publicly traded company pioneering RNA cell therapy for the treatment of autoimmune disease – – Cartesian’s wholly owned pipeline includes a Phase 2 lead asset, Descartes-08, for which deep and durable responses have been ...
Message Board Posts | Selecta Biosciences Inc. (NASDAQ:SELB)
Subject | By | Source | When |
---|---|---|---|
Very interesting on no news? | subslover | investorshub | 03/21/2023 11:43:45 AM |
On June 22, 2022, Selecta Biosciences, Inc. (the | subslover | investorshub | 06/23/2022 2:07:19 PM |
I believe we are watching a beginning of | robertus | investorshub | 06/16/2022 9:56:11 PM |
Anybody here? Things are picking up. | m1ocha | investorshub | 06/16/2022 1:06:48 PM |
No comments since May. Is anyone monitoring | VApopeye | investorshub | 10/21/2021 3:40:25 PM |
News, Short Squeeze, Breakout and More Instantly...
Selecta Biosciences Inc. Company Name:
SELB Stock Symbol:
NASDAQ Market:
Selecta Biosciences Inc. Website:
Selecta Biosciences Inc (NASDAQ: SELB) and Cartesian Therapeutics Inc announced a reverse merger in an all-stock deal, with Selecta ...
Selecta Biosciences Inc (NASDAQ: SELB) and Cartesian Therapeutics Inc announced a reverse merger in an all-stock deal, with Selecta ...
– Merger creates a fully integrated, publicly traded company pioneering RNA cell therapy for the treatment of autoimmune disease – – Cartesi...